NG
ABBV icon

Novem Group’s AbbVie ABBV Stock Holding History

Novem Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.21M Buy
8,784
+33
+0.4% +$7.1K 0.22% 96
2026
Q1 		$1.9M Sell
8,751
-82
-0.9% -$18.2K 0.22% 91
2025
Q4 		$2.02M Buy
8,833
+180
+2% +$41K 0.23% 84
2025
Q3 		$2M Buy
8,653
+57
+0.7% +$11.6K 0.23% 87
2025
Q2 		$1.6M Buy
8,596
+404
+5% +$75.1K 0.2% 88
2025
Q1 		$1.72M Buy
8,192
+1,612
+24% +$313K 0.24% 80
2024
Q4 		$1.17M Buy
+6,580
New +$1.21M 0.17% 107

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Novem Group's ABBV Position: Q2 2026 in Review

Novem Group increased its AbbVie (ABBV) stake by 0.38% in Q2 2026, buying an estimated $7.1K and bringing the position to 8,784 shares worth $2.21M. The position accounts for 0.22% of the portfolio, ranked #96.

Novem Group first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Novem Group held 8,784 shares of AbbVie worth $2.21M as of Q2 2026.
  • Novem Group bought 33 AbbVie shares in Q2 2026, an estimated $7.1K.
  • AbbVie made up 0.22% of Novem Group's portfolio in Q2 2026, its #96 holding.
  • Novem Group first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Novem Group's 13F filing for Q2 2026, filed 21 Jul 2026.